This inventor holds 5 USPTO granted patents. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1990-1992.
Company Filing History:
Years Active: 1990-1992
Title: Kunihide Oka: Innovator in Pharmaceutical Crystallization
Introduction
Kunihide Oka is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of pharmaceutical crystallization, holding a total of 5 patents. His work focuses on the development of high-purity crystalline forms that enhance the efficacy of pharmaceutical compounds.
Latest Patents
Among his latest patents, Oka has developed alpha crystals of tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl]methane. This invention provides alpha crystals that occur as round granular crystals with high purity, uniform grain size, narrow grain size distribution, and good flowability. Additionally, he has disclosed novel individual alpha-form particle crystals of tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl]methane along with the process for their production.
Career Highlights
Kunihide Oka is currently associated with Yoshitomi Pharmaceutical Industries, Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the understanding of crystalline forms and their applications in drug formulation.
Collaborations
Oka has collaborated with notable colleagues such as Masayoshi Gohbayashi and Koichi Takee. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.
Conclusion
Kunihide Oka's contributions to pharmaceutical crystallization exemplify the importance of innovation in enhancing drug efficacy. His patents reflect a commitment to advancing the field and improving patient outcomes.